Not recruiting yet
Safety and Efficacy Study of Single-port Robotic Versus Multi-port Robotic Radical Rectal Cancer Surgery
NCT06943690 · Ruijin Hospital · Updated 24 April 2025
- What is being tested
- Single-port robotic surgery; Multi-port robotic surgery
- For
- Rectal Cancer; Surgery
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 80 years. About 212 people. The full rules are on the registry page.
- Where
- China (4 sites)
- When
- Starts or started May 2025, ends June 2027. Registered 24 April 2025.
- Results
- None posted yet.
In the researchers' words
This study is designed to evaluate the safety and efficacy of single-port robotic surgery compared to multi-port robotic surgery for rectal cancer.
Sites
- The First Affiliated Hospital of Henan University of Science & TechnologyLuoyang, Henan, China
- Shandong Provincial Hospital Affiliated to Shandong First Medical UniversityJinan, Shandong, China
- Ruijin Hospital, Shanghai Jiaotong University School of MedicineShanghai, Shanghai Municipality, China
- The First Affiliated Hospital of Wenzhou Medical UniversityWenzhou, Zhejiang, China